Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 59,600 KRW
Change Today -1,900.00 / -3.09%
Volume 31.0K
003850 On Other Exchanges
Korea SE
As of 2:26 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for boryung pharmaceutical co (003850)

Year over year, Boryung Pharmaceutical Co., Ltd. has been able to grow revenues from 327.3B KRW to 359.5B KRW. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 56.94% to 55.45%. This was a driver that led to a bottom line growth from 14.1B KRW to 21.6B KRW.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
TOTAL REVENUES308,005.5312,075.0327,278.7359,491.0
Cost of Goods Sold181,638.9185,733.5186,354.0199,322.6
GROSS PROFIT126,366.6126,341.5140,924.7160,168.4
Selling General & Admin Expenses, Total92,408.193,322.195,531.3107,722.7
R&D Expenses25,556.428,226.124,502.325,750.1
Depreciation & Amortization, Total1,887.11,744.01,754.42,260.6
OTHER OPERATING EXPENSES, TOTAL119,851.7123,292.2121,788.0135,733.3
OPERATING INCOME6,514.93,049.319,136.824,435.0
Interest Expense-2,372.3-2,441.0-1,665.9-1,147.6
Interest and Investment Income3.3160.3103.012.4
NET INTEREST EXPENSE-2,369.0-2,280.7-1,563.0-1,135.3
Currency Exchange Gains (Loss)133.436.7-151.2241.6
Other Non-Operating Income (Expenses)3,193.44,442.62,857.65,073.4
EBT, EXCLUDING UNUSUAL ITEMS7,472.75,247.920,280.228,614.8
Gain (Loss) on Sale of Assets17.6105.033.3--
EBT, INCLUDING UNUSUAL ITEMS7,490.35,352.920,313.528,614.8
Income Tax Expense1,312.2-4,048.16,186.97,024.2
Earnings from Continuing Operations6,178.19,401.014,126.621,590.6
NET INCOME6,178.19,401.014,126.621,590.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS6,178.19,401.014,126.621,590.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS6,178.19,401.014,126.621,590.6

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003850:KS 59,600.00 KRW -1,900.00

003850 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,034 GBp -86.50
View Industry Companies

Industry Analysis


Industry Average

Valuation 003850 Industry Range
Price/Earnings 20.1x
Price/Sales 1.2x
Price/Book 2.5x
Price/Cash Flow 18.8x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BORYUNG PHARMACEUTICAL CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at